1 week Ago By ABMN Staff
Certuity LLC acquired a new position in shares of The Clorox Company ( NYSE:CLX – Free Report ) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 3,127 shares of the company’s stock, valued at approximately $427,000. Other institutional investors also recently bought and sold shares of the company.
Northwest Financial Advisors purchased a new position in Clorox during the fourth quarter worth about $29,000. GoalVest Advisory LLC acquired a new stake in shares of Clorox during the first quarter valued at about $31,000. First Foundation Advisors acquired a new stake in shares of Clorox during the first quarter valued at about $31,000.
Core Wealth Advisors Inc. acquired a new stake in shares of Clorox during the fourth quarter valued at about $29,000. Finally, Innealta Capital LLC acquired a new stake in shares of Clorox during the second quarter valued at about $30,000.
78.53% of the stock is owned by hedge funds and other institutional investors. Clorox Stock Performance Shares of CLX opened at $164.
75 on Monday. The company has a debt-to-equity ratio of 5.04, a quick ratio of 0.
63 and a current ratio of 1.03. The stock has a market capitalization of $20.
46 billion, a P/E ratio of 85.36, a P/E/G ratio of 3.21 and a beta of 0.
40. The company’s fifty day moving average is $142.93 and its two-hundred day moving average is $142.
78. The Clorox Company has a 1 year low of $114.68 and a 1 year high of $166.
49. Clorox Increases Dividend The business also recently declared a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Wednesday, August 14th were paid a dividend of $1.
22 per share. The ex-dividend date was Tuesday, August 13th. This is a boost from Clorox’s previous quarterly dividend of $1.
20. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.
96%. Clorox’s dividend payout ratio is 252.85%.
Analyst Ratings Changes A number of research analysts recently weighed in on the stock. JPMorgan Chase & Co. dropped their price objective on shares of Clorox from $150.
00 to $148.00 and set a “neutral” rating for the company in a report on Friday, August 2nd. Argus upgraded shares of Clorox to a “hold” rating in a report on Tuesday, June 4th.
Wells Fargo & Company lowered their price target on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a report on Wednesday, July 10th.
Barclays boosted their price target on shares of Clorox from $122.00 to $130.00 and gave the stock an “underweight” rating in a report on Monday, August 5th.
Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd.
Six research analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $143.50.
Check Out Our Latest Stock Report on Clorox Clorox Company Profile ( Free Report ) The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
See Also Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter ..
